GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $140.23 $156.84 Thursday, 18th Apr 2024 ASND stock ended at $140.89. This is 0.90% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 2.10% from a day low at $140.23 to a day high of $143.18.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
2021-03-18 $144.00 $147.48 $142.08 $142.84 153 765
2021-03-17 $145.85 $148.00 $143.00 $144.00 125 977
2021-03-16 $147.79 $148.47 $142.32 $147.00 209 906
2021-03-15 $148.26 $150.16 $145.05 $147.00 315 181
2021-03-12 $149.00 $150.93 $145.31 $149.25 107 365
2021-03-11 $146.42 $151.93 $144.21 $150.00 138 417
2021-03-10 $145.58 $146.26 $142.85 $143.99 101 157
2021-03-09 $142.28 $148.79 $142.28 $145.07 102 404
2021-03-08 $145.00 $148.00 $140.31 $141.26 235 421
2021-03-05 $144.66 $146.91 $136.58 $146.91 237 328
2021-03-04 $152.63 $154.45 $140.45 $143.45 576 589
2021-03-03 $154.42 $154.94 $151.44 $152.90 220 621
2021-03-02 $156.53 $156.72 $151.98 $155.13 141 940
2021-03-01 $155.83 $157.96 $152.99 $156.30 118 599
2021-02-26 $158.48 $159.22 $150.76 $154.97 269 190
2021-02-25 $153.09 $159.74 $152.11 $158.66 310 673
2021-02-24 $152.88 $156.03 $150.89 $153.84 130 198
2021-02-23 $153.43 $154.99 $150.81 $152.89 122 199
2021-02-22 $154.85 $158.61 $152.31 $153.38 229 336
2021-02-19 $159.96 $162.65 $157.45 $158.56 94 008
2021-02-18 $166.96 $166.96 $158.49 $158.49 258 457
2021-02-17 $160.52 $169.00 $158.41 $168.19 186 727
2021-02-16 $161.97 $163.98 $159.14 $160.65 261 507
2021-02-12 $149.18 $160.67 $147.86 $160.67 351 551
2021-02-11 $155.00 $155.00 $147.98 $149.17 221 480
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT